Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local and systemic immune response to intravesical BCG in superficial bladder cancer
2008-004677-18Phase 4Active
- Sponsor
- CHU de Nantes
- Start
- Oct 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bcg vaccine in bladder cancer, sponsored by CHU de Nantes. Primary endpoint: Correlation between blood and urine cytokine production. Started Oct 2008; status: active.
02
Drugs
bcg vaccine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on 2008-004677-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004677-18.